MedPath

Effects of synbiotics in controlling blood sugar in children with type 1 diabetes

Not Applicable
Conditions
Diabetes.
Diabetes mellitus due to underlying condition
Registration Number
IRCT20190831044653N2
Lead Sponsor
Bojnourd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
28
Inclusion Criteria

Children with type 1 diabetes (diagnosis based on HbA1C higher than 6.5 or fasting blood glucose equal to 126 mg / dl in two occasions or high blood sugar levels of over 200 with symptoms of polyuria and polydipsia, Who are treated with insulin ranged from 0.7 to 2 units per kg body weight per day (types of insulin are Lantus, Novorepid, Levemir, Regular, NPH, Apidra)
Age range from 3 to 14 years old
6.5<=HbA1C <=10.5
No antibiotics intake two months before enrollment
No probiotic intake two weeks before enrollment
No history of gastrointestinal infection two weeks before enrollment
Absence of chronic gastrointestinal diseases such as inflammatory bowel disease, celiac disease, food allergies, hypothyroidism

Exclusion Criteria

Patient adherence to the treatment less than 80% for probiotics
Discontinuing insulin therapy
Diagnose of celiac or hypothyroidism during the therapy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemoglobin A1c level. Timepoint: At the beginning of the study and 3 and 6 months after that. Method of measurement: Blood test.;Fasting blood sugar. Timepoint: At the beginning of the study and 3 and 6 months after that. Method of measurement: Blood test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath